Agios Pharmaceuticals, Inc. (AGIO)
33.68
+0.36
(+1.08%)
USD |
NASDAQ |
Aug 31, 16:00
33.67
-0.01
(-0.03%)
After-Hours: 20:00
Agios Pharmaceuticals Total Long Term Debt (Quarterly) : 11.95M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.95M |
| March 31, 2026 | 16.94M |
| December 31, 2025 | 21.82M |
| September 30, 2025 | 26.53M |
| June 30, 2025 | 31.17M |
| March 31, 2025 | 35.74M |
| December 31, 2024 | 40.21M |
| September 30, 2024 | 44.52M |
| June 30, 2024 | 48.76M |
| March 31, 2024 | 52.94M |
| December 31, 2023 | 56.99M |
| September 30, 2023 | 60.83M |
| June 30, 2023 | 64.62M |
| March 31, 2023 | 68.35M |
| December 31, 2022 | 72.00M |
| September 30, 2022 | 75.58M |
| June 30, 2022 | 79.11M |
| March 31, 2022 | 82.86M |
| December 31, 2021 | 86.27M |
| September 30, 2021 | 89.25M |
| June 30, 2021 | 92.98M |
| March 31, 2021 | 95.62M |
| December 31, 2020 | 98.11M |
| September 30, 2020 | 100.42M |
| June 30, 2020 | 102.67M |
| Date | Value |
|---|---|
| March 31, 2020 | 104.89M |
| December 31, 2019 | 107.02M |
| September 30, 2019 | 108.10M |
| June 30, 2019 | 110.07M |
| March 31, 2019 | 66.01M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Biogen, Inc. | 8.355B |
| Insmed, Inc. | 741.01M |
| Alnylam Pharmaceuticals, Inc. | 2.942B |
| Exelixis, Inc. | 165.93M |